HUTCHMED (HCM) Competitors $15.69 +0.32 (+2.08%) Closing price 03/14/2025 04:00 PM EasternExtended Trading$15.70 +0.01 (+0.06%) As of 03/14/2025 04:08 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends HCM vs. RDY, SRPT, PCVX, QGEN, ASND, ROIV, LNTH, RVMD, LEGN, and TGTXShould you be buying HUTCHMED stock or one of its competitors? The main competitors of HUTCHMED include Dr. Reddy's Laboratories (RDY), Sarepta Therapeutics (SRPT), Vaxcyte (PCVX), Qiagen (QGEN), Ascendis Pharma A/S (ASND), Roivant Sciences (ROIV), Lantheus (LNTH), Revolution Medicines (RVMD), Legend Biotech (LEGN), and TG Therapeutics (TGTX). These companies are all part of the "pharmaceutical products" industry. HUTCHMED vs. Dr. Reddy's Laboratories Sarepta Therapeutics Vaxcyte Qiagen Ascendis Pharma A/S Roivant Sciences Lantheus Revolution Medicines Legend Biotech TG Therapeutics HUTCHMED (NASDAQ:HCM) and Dr. Reddy's Laboratories (NYSE:RDY) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, risk, dividends, community ranking, institutional ownership, profitability, valuation, analyst recommendations and media sentiment. Does the media prefer HCM or RDY? In the previous week, Dr. Reddy's Laboratories had 4 more articles in the media than HUTCHMED. MarketBeat recorded 7 mentions for Dr. Reddy's Laboratories and 3 mentions for HUTCHMED. HUTCHMED's average media sentiment score of 0.99 beat Dr. Reddy's Laboratories' score of 0.86 indicating that HUTCHMED is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment HUTCHMED 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Dr. Reddy's Laboratories 5 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals & insiders have more ownership in HCM or RDY? 8.8% of HUTCHMED shares are held by institutional investors. Comparatively, 3.8% of Dr. Reddy's Laboratories shares are held by institutional investors. 3.6% of HUTCHMED shares are held by company insiders. Comparatively, 2.0% of Dr. Reddy's Laboratories shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Which has more risk and volatility, HCM or RDY? HUTCHMED has a beta of 0.77, meaning that its stock price is 23% less volatile than the S&P 500. Comparatively, Dr. Reddy's Laboratories has a beta of 0.48, meaning that its stock price is 52% less volatile than the S&P 500. Do analysts prefer HCM or RDY? HUTCHMED currently has a consensus target price of $19.00, suggesting a potential upside of 21.10%. Dr. Reddy's Laboratories has a consensus target price of $17.00, suggesting a potential upside of 33.92%. Given Dr. Reddy's Laboratories' stronger consensus rating and higher probable upside, analysts plainly believe Dr. Reddy's Laboratories is more favorable than HUTCHMED.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score HUTCHMED 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Dr. Reddy's Laboratories 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50 Which has stronger valuation and earnings, HCM or RDY? Dr. Reddy's Laboratories has higher revenue and earnings than HUTCHMED. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHUTCHMED$610.81M4.48$100.78MN/AN/ADr. Reddy's Laboratories$311.31B0.03$668M$0.6320.15 Does the MarketBeat Community believe in HCM or RDY? Dr. Reddy's Laboratories received 6 more outperform votes than HUTCHMED when rated by MarketBeat users. However, 66.32% of users gave HUTCHMED an outperform vote while only 59.33% of users gave Dr. Reddy's Laboratories an outperform vote. CompanyUnderperformOutperformHUTCHMEDOutperform Votes31566.32% Underperform Votes16033.68% Dr. Reddy's LaboratoriesOutperform Votes32159.33% Underperform Votes22040.67% Is HCM or RDY more profitable? Dr. Reddy's Laboratories has a net margin of 17.25% compared to HUTCHMED's net margin of 0.00%. Dr. Reddy's Laboratories' return on equity of 17.87% beat HUTCHMED's return on equity.Company Net Margins Return on Equity Return on Assets HUTCHMEDN/A N/A N/A Dr. Reddy's Laboratories 17.25%17.87%12.32% SummaryDr. Reddy's Laboratories beats HUTCHMED on 10 of the 16 factors compared between the two stocks. Remove Ads Get HUTCHMED News Delivered to You Automatically Sign up to receive the latest news and ratings for HCM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HCM vs. The Competition Export to ExcelMetricHUTCHMEDPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.74B$7.03B$5.68B$8.14BDividend YieldN/A2.75%4.40%4.09%P/E RatioN/A6.2923.9019.07Price / Sales4.48232.75395.6188.27Price / Cash24.5165.6738.1134.64Price / Book3.676.596.834.29Net Income$100.78M$142.18M$3.20B$247.56M7 Day Performance-5.08%-1.29%6.58%-0.84%1 Month Performance13.70%-8.94%-0.31%-9.37%1 Year Performance-10.90%-5.83%13.04%4.01% HUTCHMED Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HCMHUTCHMED2.1052 of 5 stars$15.69+2.1%$19.00+21.1%-10.9%$2.74B$610.81M0.001,988Upcoming EarningsGap DownRDYDr. Reddy's Laboratories3.0458 of 5 stars$12.70-1.7%$17.00+33.9%-15.6%$10.60B$311.31B20.2124,800News CoverageSRPTSarepta Therapeutics4.7647 of 5 stars$99.69-3.2%$170.41+70.9%-21.0%$9.67B$1.90B79.751,314Insider TradePCVXVaxcyte2.3533 of 5 stars$68.89-3.2%$147.50+114.1%+6.7%$8.87BN/A-14.98160Analyst ForecastNews CoveragePositive NewsQGENQiagen3.9079 of 5 stars$38.93-2.1%$47.71+22.6%-7.7%$8.64B$1.98B108.405,967Short Interest ↓ASNDAscendis Pharma A/S3.066 of 5 stars$138.18-5.2%$202.36+46.4%+2.9%$8.39B$363.64M-19.461,017Positive NewsROIVRoivant Sciences2.0421 of 5 stars$10.58-0.6%$18.08+70.9%+5.1%$7.55B$122.59M-70.53860LNTHLantheus4.6132 of 5 stars$110.01+3.5%$132.86+20.8%+73.8%$7.53B$1.53B18.30700Short Interest ↓Positive NewsRVMDRevolution Medicines4.2104 of 5 stars$36.82-6.1%$66.31+80.1%+22.9%$6.85B$742,000.00-10.26250Positive NewsLEGNLegend Biotech1.9915 of 5 stars$34.03-3.5%$79.50+133.6%-41.9%$6.22B$520.18M-35.821,800Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageTGTXTG Therapeutics3.0113 of 5 stars$39.23+2.1%$40.67+3.7%+168.3%$6.16B$329.00M-392.26290Positive News Remove Ads Related Companies and Tools Related Companies RDY Alternatives SRPT Alternatives PCVX Alternatives QGEN Alternatives ASND Alternatives ROIV Alternatives LNTH Alternatives RVMD Alternatives LEGN Alternatives TGTX Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HCM) was last updated on 3/16/2025 by MarketBeat.com Staff From Our PartnersElon Warns “America Is Broke”. Trump’s Plan Inside.Elon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredYour Wealth is Under AttackHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredBITCOINDid you miss out on the 1000%+ gains of Bitcoin over the past 5 years? If so, you don't want to miss this.....Awesomely, LLC | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredDOGE could send 6 AI stocks through the roofStay alert for Elon Musk and the Department of Government Efficiency's next move … Expect an announcement f...Weiss Ratings | SponsoredForget Trump’s Tariffs, This March Event Is BiggerWhile everyone is distracted by Trump’s tariffs and a potential trade war… There’s something much bigger ha...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HUTCHMED (China) Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share HUTCHMED With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HCM Stock Alerts